Diversified Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,880
Closed -$276K 1130
2026
Q1
$276K Sell
4,880
-9,417
-66% -$549K 0.01% 871
2025
Q4
$850K Buy
14,297
+9,265
+184% +$504K 0.02% 494
2025
Q3
$273K Buy
+5,032
New +$288K 0.01% 833
2025
Q1
Sell
-3,958
Closed -$260K 942
2024
Q4
$260K Buy
3,958
+8
+0.2% +$536 0.01% 781
2024
Q3
$278K Buy
+3,950
New +$330K 0.01% 747
2016
Q3
Sell
-10,130
Closed -$788K 292
2016
Q2
$788K Sell
10,130
-1,375
-12% -$117K 0.09% 189
2016
Q1
$949K Buy
11,505
+1,145
+11% +$93.2K 0.1% 178
2015
Q4
$1.08M Sell
10,360
-375
-3% -$39.2K 0.12% 174
2015
Q3
$1.13M Sell
10,735
-9,405
-47% -$1.26M 0.12% 174
2015
Q2
$2.75M Buy
20,140
+8,405
+72% +$1.04M 0.26% 90
2015
Q1
$1.46M Hold
11,735
0.13% 166
2014
Q4
$1.06M Buy
+11,735
New +$976K 0.1% 222
2014
Q2
$863K Buy
+13,865
New +$838K 0.07% 279
2013
Q4
$719K Sell
10,225
-700
-6% -$47.5K 0.07% 250
2013
Q3
$788K Buy
10,925
+1,700
+18% +$113K 0.08% 244
2013
Q2
$515K Buy
+9,225
New +$575K 0.06% 296

Other funds holding BMRN

Diversified Trust's BMRN Position: Q2 2026 in Review

Diversified Trust sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 4,880 shares — an estimated $276K sold.

Diversified Trust first reported a position in BMRN in Q2 2013 and held it in 16 quarters. The position peaked at $2.75M in Q2 2015. 56 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Diversified Trust reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Diversified Trust sold 4,880 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $276K.
  • Diversified Trust first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Diversified Trust's BioMarin Pharmaceuticals position peaked at $2.75M in Q2 2015.
  • 56 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.